Cadila Healthcare board to consider unaudited financial result

15 Oct 2013 Evaluate

Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on October 31, 2013,to consider, approve the unaudited financial results for the quarter / half year ended on September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

904.85 -15.95 (-1.73%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×